Your browser is unsupported

We recommend using the latest version of IE11, Edge, Chrome, Firefox or Safari.

Recent Funding

  • New ACS. Kaori Yamada. Developing Preventive Strategy for Uveal Melanoma Metastasis
  • New MPI R01. Kostadin Pajcini and Jae-Won Shin. Engineering extracellular vesicles for therapeutic receptor activation.
  • New R01. Kostadin Pajcini. Notch signaling regulates stem cell function in the fetal liver hematopoietic niche.
  • New R01. Bisheng Zhou. Perivascular macrophages – a new player in regulating endothelial repair following lung vascular injury
  • MPI R01. Asrar Malik and Yulia Komarova. Programming of PMN host-defense function during transendothelial migration
  • New R01. Sang Ging Ong. Systems Pharmacology Model of Heart Failure with Preserved Ejection Fraction
  • New R01. Dolly Mehta. Targeting mechanisms activating ion-channel for preventing acute lung injury
  • New R01. Jae-Won Shin. Therapeutic nanoscale matrimeres
  • PPG. Dolly Mehta, Asrar B. Malik, Jalees Rehman, Konstantinos Chronis, Gary Mo, Yoshikazu Tsukasaki. The Lung Endothelium as an Instructive Niche for the Innate Immune System during
    Vascular Injury
  • New R01. Soroush Tahmasebi. Translational regulation of tissue resident macrophages by GCN2
  • New R01. Sandra Pinho. Mechanisms of hematopoietic stem cell engraftment
  • NIH R35(MIRA). Gary CH Mo. Pyroptosis is a Trial-by-Fire Program
  • NIH R35(MIRA). Andrei V Karginov. Regulation of endothelial cell invasion, migration and cell junction plasticity
  • PPG. Malik, Mehta, Rehman, Karginov, Mo, Dudek. Macrophage Plasticity in Inflammatory Lung Injury
  • New R01. Kim Kiwook. Role of membrane-associated macrophages in health and inflammation.
  • DoD. Yulia Komarova. COVID19 Novel Pharmacological interventions for ARDS of COVID-19 patients: Investigational new drug-enabling studies.